Content matching 'personalized medicine'
Latest developments compiled from 1–30 September 2014
Today marks the start of the 10th WSCS, taking place in San Antonio, Texas
Recently, Japan has given two prominent topics, bad and good, to the global regenerative medicine community. The former is the over-promoted but fabricated STAP stem cell papers, and the latter is a rather unusual bold move by Japanese government to start flexible and relaxed regulation to advance the stem cell-based therapy. Then, what are happening in Japan?
Why the FDA’s CAR-T approval sends strong signal to cell therapy industry: an interview with Martin Lamb
Spotlight on immunotherapy, Spotlight on commercialization and translation, Spotlight on cell therapy regulation, Cell therapy, Latest news & views, Industry developments, Manufacturing & scale-up